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Cytochrome P450 2E1 null mice provide novel protection
against cisplatin-induced nephrotoxicity and apoptosis
HUA LIU and RADHAKRISHNA BALIGA
Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi
Cytochrome P450 2E1 null mice provide novel protection against ops primarily in the S3 segment of the proximal tubule
cisplatin-induced nephrotoxicity and apoptosis. [2, 3]. Reactive oxygen metabolites (ROM) have been
Background. Reactive oxygen metabolites (ROM) are im- implicated to play an important role in cisplatin-inducedportant mediators of cisplatin-induced nephrotoxicity and apo-
renal cell injury [4–7]. There is little information as to theptosis. The site and source of generation of these metabolites are
intracellular source and site for the generation of ROMnot well defined. Cytochrome P450 (CYP) are heme-containing
enzymes that can generate ROM during the oxidative metabo- in this model.
lism of exogenous and endogenous compounds. CYP2E1 was Cytochrome P450 (CYP) is a group of hemeproteins
identified and localized to the kidney proximal tubule. There that act primarily as mono-oxygenases in the synthesisis evidence to suggest that CYP2E1 is involved in the generation
and metabolism of many exogenous and endogenous com-of ROM.
pounds [8]. During the nicotinamide adenine dinucleo-Methods. The current study was performed utilizing CYP2e1
null mice (CYP2e1/). Cisplatin nephrotoxicity was induced tide phosphate (NADPH)-dependent electron transfer
in mice by single intraperitoneal injection of cisplatin and ani- CYP can function as oxidases and generate hydrogen per-
mals were sacrificed 72 hours later. Renal function was assessed
oxide (H2O2) and superoxide anion [9, 10]. These initialand various biochemical tests were performed, including histo-
ROM may oxidatively degrade the CYP hemeproteinlogic studies.
Results. CYP2e1/ demonstrated marked functional and and promote the release of iron leading to the generation
histologic protection against cisplatin-induced renal injury. In- of the potent oxidants. Recent studies, including ours,
cubation of CYP2e1/ kidney slices with cisplatin resulted indicate that the iron rich enzyme, CYP, may serve as
in significant decrease in the generation of ROM and attenua-
an important source of catalytic iron in models of tissuetion of cytotoxicity as compared to that of wild-type mice
injury, including cisplatin nephrotoxicity [11–15].(CYP2e1/). Cisplatin-induced apoptosis was also markedly
reduced in the CYP2e1/mice. Direct incubation of cisplatin CYP2E1 is clinically and toxicologically important and
with the microsomes isolated from CYP2e1/ kidney cortex is constitutively expressed in the liver and many other
produced significant decrease in the generation of hydrogen tissues, including the kidney [16]. This enzyme is also up-peroxide, catalytic iron content, and hydroxyl radical formation
regulated in certain pathophysiologic conditions such ascompared to CYP2e1/ microsomes.
diabetes [17], starvation [18], and obesity [19]. CYP2E1Conclusion. Our results thus demonstrate a pivotal role of
CYP2E1 in cisplatin-induced nephrotoxicity and apoptosis. We exhibits a unique ability to potentiate an iron catalyzed
postulate that the interaction of cisplatin with CYP2E1 results Fenton-type reaction and an increased rate of micro-
in the generation of ROM that causes renal injury and initiates somal lipid peroxidation [20, 21]. We have identified andapoptosis.
localized CYP2E1 to the proximal tubule of the mouse
kidney. A CYP2e1 null mouse (CYP2e1/) line has been
established with no phenotypic or pathologic abnormali-Cisplatin is one of the most effective chemotherapeu-
ties indicating that CYP2E1 is not essential for the nor-tic agents used in the treatment of a variety of human
mal mammalian development or physiologic homeosta-solid tumors [1]. The most common adverse effect lim-
sis [22]. When challenged with cisplatin, the CYP2e1/iting the use of cisplatin is the nephrotoxicity that devel-
mice provided marked functional and histologic protec-
tion against cisplatin-induced nephrotoxicity and apo-
ptosis. Our results thus indicate an important role ofKey words: cytochrome P450 2E1, reactive oxygen metabolites, cis-
platin, nephrotoxicity, apopotosis, knockout mice, heme oxygenase-1. CYP2E1 in cisplatin-induced renal cell injury and initia-
tion of apoptosis.Received for publication September 25, 2002
We also looked at the induction of heme oxygenaseand in revised form November 25, 2002
Accepted for publication December 17, 2002 (HO-1), which is a rate-limiting enzyme for heme metab-
olism that can be up-regulated in response to an increase 2003 by the International Society of Nephrology
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in heme and iron. p21, a cyclin kinase inhibitor, which Preparation of microsome fraction
has been shown to prevent DNA-damaged cells from Kidney cortex was suspended in an extraction buffer
entering the cell cycle, was also examined [23]. containing 20 mmol/L Tris-HCl, pH 7.4, 0.25 mol/L su-
crose, 1 mmol/L ethylenediaminetetraacetic acid (EDTA)
and protease inhibitor cocktail (25 mg protein/1 L ofMETHODS
cocktail, Sigma Chemical Co., St. Louis, MO, USA) and
CYP2e1 knockout mice frozen at 80C. Subsequently, the glomeruli were
thawed and sonicated [27]. The homogenate was centri-Mice (strain 129/SV) carrying a deletion of CYP2e1
fuged at 15,000g for 20 minutes at 4C. The supernatantgene have been successfully produced in the laboratory
obtained was again centrifuged at 105,000g for 60 min-of Dr. Gonzalez at the National Institutes of Health.
utes at 4C. The sedimented microsomal pellet was resus-The CYP2e1 gene was isolated from a 129/SV mouse
pended in above extraction buffer to give a protein con-(CYP2E1 wild-type mouse, CYP2e1/) genomic li-
centration 10 mg/mL [28].brary that contained the complete coding region. The
gene was disrupted by the replacement of exon 2 with
Western blot analysis
the PGK-NEO cassette [22]. Mice homozygous for the
The microsome fraction obtained was subjected todisrupted CYP2e1 allele were born and developed nor-
sodium dodecyl sulfate-polyacrylamide gel electropho-mally with no obvious phenotypic divergence from wild-
resis (SDS-PAGE) in 1 mm slab gels. The separatedtype mice. The clone of mice was maintained by breeding
forms were transferred from the gel to a nitrocelluloseCYP2e1/ males with CYP2e1/ females. A com-
sheet using a Mini Trans-Blot electroblotting unit (Bio-plete absence of CYP2E1 protein and mRNA in the
Rad, Hercules, CA, USA). The primary antibodies weremice was confirmed by immunoblotting and Northern
anti-CYP2E1 (MFO 100, StressGen, Victoria, BC, Can-
blot. The CYP2e1 knockout mice provide us with a novel ada), anti-HO-1 (SPA 895, StressGen, Victoria, BC,
toxicologic model that enables the determination of the Canada), and monoclonal anti-p21 (sc-6246, Santa Cruz
precise contribution of the particular CYP2E1 isozyme Biotechnology, Inc., Santa Cruz, CA, USA). Subsequent
toward cisplatin-induced acute renal failure (ARF). to primary and secondary antibody (peroxidase-labeled)
treatment, the blots were visualized by enhanced chemi-Cisplatin-induced ARF
luminescence method [29].
Cisplatin model of ARF was induced in mice by single
Immunohistochemistryintraperitoneal injection of cisplatin at a dose of 10 mg/kg
body weight as determined by a dose-dependent pilot study Kidney cortical sections were fixed in 10% buffered
in our laboratory (data not shown). Male CYP2e1/ and formalin for 6 hours and embedded in paraffin. After
CYP2e1/ mice weighing 25 to 30 g were allowed free deparaffinization and antigen retrieval, the sections were
immunolabeled and visualized according to an avidin-access to rodent chow (Purina) and water. The animals
biotin complex (ABC) method [30].were sacrificed at 72 hours after cisplatin injection. Renal
function was assessed by blood urea nitrogen (BUN),
Immunoelectronmicroscopyserum creatinine, creatinine clearance, and kidney his-
Kidney cortical sections were fixed in 4% paraformal-tology.
dehyde, postfixed in osmium tetraoxide, dehydrated and
embedded in LR-White resin. Semithin sections wereKidney histology
cut to ensure that the sections contained glomeruli, thenThree to five mice in each group were obtained for
70 nm ultrathin sections were cut from selected blockskidney histology. Renal function in these subsets was not
and placed on nickel grids. Grids were incubated withdifferent from the overall experimental groups. Renal
normal goat serum for 30 minutes, then placed in mono-tubule histologic grading was as follows: 0, normal; I, area
clonal anti-CYP2E1 antibody for overnight at 4C. Grids
of tubular epithelial cell swelling, vacuolar degeneration, were rinsed in Tris buffer and then incubated in antirab-
necrosis, and desquamation involving 25% of cortical bit immunoglobulin G (IgG) antibody (BB Interna-
tubules; II, similar changes involving 25% but 50%; tional, Cardiff, UK, 1:100 dilution) conjugated with 10
III, similar changes involving 50% but 75% tubules; nm gold for 1 hour at room temperature. Grids were
IV, similar changes involving 75%. rinsed in buffer, dried, and viewed with a Leo 906 trans-
mission electron microscope.
Bleomycin-detectable iron assay
Reverse transcription-polymerase chainIron capable of catalyzing free radical reactions was
reaction (RT-PCR)measured by bleomycin-detectable iron assay as de-
scribed by Gutteridge, Rowley, and Halliwell [24, 25] RNA was isolated from the kidney cortex using TRIzol
Reagent (GibcoBRL, Gaithersburg, MD, USA). RT ofand as detailed in our previous studies [4, 11, 12, 26].
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Fig. 1. Characterization of CYP2e1/ mice
by immunohistochemistry (A) and Western blot
(B). Western blot detection of CYP2E1 was
performed by using the microsome isolated
from liver. CYP2E1 is expressed in CYP2e1/
mice both in liver and kidney proximal tubules
but not in CYP2e1/ mice.
0.5 g of total RNA and PCR were carried out by one-
step RT-PCR protocol using AccessQuick RT-PCR sys-
tem (Promega, Madison, WI, USA). p21 primers de-
scribed by Gartel et al [31] were purchased from Gibco
BRL. The sense primer was 5-AGCCTGAAGACTGT
GAT GGG-3, and the antisense 5-AAAGTTCCAC
CGT TCTCGG-3. The amplification product length was
228 bp. GAPDH sense was 5-TCCCTCAAGATTG
TCAGCAA-3; and GAPDH antisense 5-AGATCC
ACAAC GGATACATT-3. The amplification condi-
tions for PCR were a hot start of 95C for 50 seconds,
followed by cycling of 1 minute at 60C, 1 minute at
72C, and 1 minute at 95C for 30 cycles. The reaction
was finished within 7 minutes at 72C. The PCR products Fig. 2. Immunoelectronmicroscopy for CYP2E1 revealed gold parti-
cles located primarily at the endoplasmic reticulum. Magnificationwere visualized on a 2% agarose gel using ethidium bro-
90,000.mide and ultraviolet transillumination.
Preparation of renal cortical slices and
incubation condition
Measurement of intracellular H2O2 generation fromRenal cortical slices were prepared as described kidney slices
by Zhang and Lindup [32]. Male CYP2e1/ and
The principle of this method is that the oxidation ofCYP2e1/mice weighing 25 to 30 g were anesthetized
2,7-dichlorofluorescin-diacetate (DCFH-DA) in the pres-and the kidneys were purfused with ice-cold saline to
ence of H2O2 produces the highly fluorescent compoundremove as much blood as possible. After removing the
2,7-dichlorofluorescin (DCF), which can be measuredkidneys, renal cortical slices were prepared using a
by a fluorometer. The intracellular generation of H2O2MclLWAIN Tissue Chopper (Surrey, England). The slices
in kidney slices was tested by a microplate assay de-(six to eight slices, 0.3 to 0.5 mm thick, weight 80 to100
scribed by Rosenkranz et al [33]. In brief, kidney slicesmg) were incubated with oxygenated medium (97 mmol/L
were incubated at 37C with equal volumes of DCFH-NaCl, 40 mmol/L KCl, 0.74 mmol/L CaCl2, 1 mmol/L
DA (10 uL/mL) and cisplatin for the planned time pe-glycine, 1 mmol/L glutamate, 0.2 mmol/L l-cysteine, and
riod. At the end of the incubation, the fluorescence inten-7.5 mmol/L sodium phosphate buffer, pH 7.4) in pres-
sity was read using a fluorescence spectrophotometerence or absence of cisplatin at 37C. The dose of cisplatin
(wavelength 485/535 nm) capable of reading microtiterutilized was based on a time- and dose-dependent study
of cisplatin cytotoxicity (data not shown). plates.
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Table 1. Renal function and catalytic iron
Blood urea nitrogen Serum creatinine Creatinine clearance Catalytic iron
mg/dL mg/dL mL/hour nmol/mg protein
CYP2e1/
Sham (N 	 6 to 9) 17
2 0.27
0.02 7.21
0.9 11.47
0.18
Cisplatin (N 	 8 to 14) 69
2a 1.55
0.23a 1.02
0.2a 38.98
3.88a
CYP2e1/
Sham (N 	 6) 15
3 0.27
0.02 7.71
0.5 6.54
0.96
Cisplatin (N 	 10) 32
4a,b 0.47
0.06b 6.24
0.8b 12.08
1.33b
Values are mean 
 SE. aP  0.05 compared to the respective control, bP  0.05 compared to CYP2E1/ mice treated with cisplatin. There is no significant
difference in the control values between CYP2e1/ and CYP2e1/.
Statistical analysis
Values are expressed as mean 
 standard error (SE).
Statistical analysis was performed using unpaired t test
(for only two groups) and analysis of variance (for more
than two groups). Statistical significance was considered
at P  0.05.
Fig. 3. The effect of cisplatin on CYP2E1 content in renal cortex and
liver of CYP2e1/ mice as evaluated by Western blot. The loss of
RESULTSCYP2E1 content in the renal cortex is injury specific since there was
no difference in the level of CYP2E1 content in the liver between the CYP2E1 was identified and localized to the renal tu-
untreated and the cisplatin-treated animals.
bules but not the glomeruli (Fig. 1A). Analysis pertaining
to the expression of CYP2E1 in the genetically altered
mice (CYP2e1/) and wild-type mice (CYP2e1/)Measurement of hydroxyl radical formation from
are summarized in Figure 1.kidney slices
Ultrastructural localization by immunogold labeling2-deoxy-d-ribose in a final concentration of 3 mmol/L
indicated that CYP2E1 is predominantly present in thewas added to the medium just prior to the incubation.
endoplasmic reticulum (Fig. 2).At the end of the incubation, the incubation medium
The renal function as measured by the BUN, serumwas collected for the measurement of hydroxyl radical
creatinine, and creatinine clearance is shown in Table 1.formation by deoxyribose degradation method as in our
On day 3 following cisplatin injection CYP2e1/ miceprevious study [34].
demonstrated significant preservation of renal function
as compared to CYP2e1/ mice.Detection of DNA fragmentation
Catalytic iron content was markedly increased in theThe kidney cortex was homogenized and lysed with a
kidneys of cisplatin-treated CYP2e1/ mice (Table 1)buffer containing 10 mmol/L Tris-HCl (pH7.5), 1 mmol/L
associated with a marked decrease in the CYP2E1 con-EDTA, 0.1 mmol/L NaCl, and 0.5% SDS. The lysates
tent as determined by Western blot (Fig. 3) and immuno-were incubated with proteinase K (0.2 mg/mL) at 50C
histochemistry (Fig. 4). The loss of CYP2E1 content inovernight. DNA was isolated from the lysates follow-
the kidneys of the CYP2e1/ mice was injury specificing the procedures as described by Ramachandra and
as there was no difference in the level of the CYP2E1Studzinski [35]. The DNA obtained was resuspended in
content in the liver between the untreated and cisplatin-a buffer (10 mmol/L Tris-HCl and 1 mmol/L EDTA) at
treated mice (Fig. 3). The catalytic iron content was1 g/mL and incubated with 0.1 U/10 g DNA of
significantly reduced in the kidneys of the CYP2e1/DNAase free RNAase cocktail (Cat # 2286, Ambion,
mice injected with cisplatin (Table 1).Austin, TX, USA). Electrophoresis was performed in
The histologic changes were graded as described in1.6% agarose gels and DNA was visualized with ethid-
the Methods section and summarized in Table 2.ium bromide.
Cisplatin-treated CYP2e1/mice had extensive epi-
Terminal deoxynucleotidyl transferase-mediated thelial cell vacuolization, swelling, desquamation, and
uridine triphosphate nick end labeling necrosis (grade 4) occurring predominantly in the proxi-
(TUNEL) staining mal convoluted tubules (Fig. 5). There were very few
changes observed in the CYP2e1/ mice treated withDetection of apoptotic cells in the kidney was performed
cisplatin (grades 0 to 1) (Fig. 5).on paraffin embedded renal tissue section utilizing a de-
Oxidant stress induces HO-1, the rate-limiting enzymetecting kit, ApopTag Plus (Cat #S7101, Intergen, Pur-
chase, NY, USA), following the manufacturer’s protocol. in heme degradation, which has been shown to be protec-
Fig. 4. Immunohistochemistry studies of the effect of cisplatin on CYP2E1 content and HO-1 induction in mouse renal cortex. The first row
shows representative photographs using primary antibodies to CYP2E1, in animals injected with saline versus animals injected with cisplatin. The
second row shows the same animals studied with primary antibodies to HO-1.
Fig. 5. Light-microscopy section of kidney.
The first row shows representative photo-
graphs of the kidney sections from normal
CYP2e1/ and CYP2e1/ mice. The sec-
ond row shows the kidney sections from the
mice treated with cisplatin. Cisplatin-treated
CYP2e1/ mice, but not CYP2e1/ mice,
had extensive epithelial cell vacuolization,
swelling, desquamation, and necrosis predom-
inantly in the proximal tubules.
Table 2. Histologic grading
Histologic grade
Group N 0 I II III IV
CYP2e1/ mice
Control 3 3
Cisplatin 5 1 4
CYP2e1/ mice
Control 3 3
Cisplatin 5 3 2
Three to five mice in each group were obtained for kidney histology. Renal
function in these subsets was not different from the overall experimental groups.
Renal tubule histologic grading was as follows: 0, normal; I, area of tubular
epithelial cell swelling, vacuolar degeneration, necrosis, and desquamation in-
Fig. 6. Western blot analysis of HO-1 induction in renal cortex ofvolving25% of cortical tubules; II, similar changes involving25% but50%;
CYP2e1/ and CYP2e1/ mice treated with 10 mg/kg intraperito-III, similar changes involving 50% but 75% tubules; IV, similar changes
involving 75%. neal injection of cisplatin.
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Fig. 7. In vitro study using kidney slices from
CYP2e1/ and CYP2e1/ mice. Hydro-
gen peroxide generation (A), catalytic iron
release (B) and hydroxyl radical formation
(C ) from the kidney slices exposed to cisplatin
(2 mmol/L for 1 hour at 37C). Cytotoxicity
of cisplatin (2 mmol/L for 2 hours at 37C)
to the kidney slices as measured by lactate
dehydrogenase (LDH) release (D). Values
are means 
 SE, N 	 4. *P  0.05 compared
to the respective control;P 0.05 compared
to the CYP2e1/ kidney slices treated with
cisplatin alone.
Fig. 8. Representative sections of terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling (TUNEL) staining for
detection of apoptotic nuclei in kidney cortex 72 hours after cisplatin injection. TUNEL-positive cells were observed in the kidney of the CYP2e1/
mice treated with cisplatin but absent in control mice and markedly reduced in CYP2e1/ mice treated with cisplatin.
tive in several models of nephrotoxic renal injury [36]. significant increase in the H2O2 generation (Fig. 7A), in-
crease in the catalytic iron content (Fig. 7B) and hydroxylAdministration of cisplatin to CYP2e1/mice resulted
in marked induction of HO-1 in the tubules as demon- radical formation (Fig. 7C). This was significantly reduced
when CYP2e1/ kidney slices were incubated withstrated by immunohistochemistry (Fig. 4) and Western
blot (Fig. 6). The induction of HO-1 was significantly cisplatin (Fig. 7 A to C). CYP2e1/ kidney slices mark-
edly reduced cisplatin-induced cytotoxicity as measuredattenuated in the CYP2e1/ mice.
The role of CYP2E1 was also examined in an in vitro by the lactate dehydrogenase (LDH) release (Fig. 7D).
Apoptotic bodies were noted in the hematoxylin andmodel of cisplatin-induced toxicity to kidney slices. Expo-
sure of CYP2e1/ kidney slices to cisplatin led to a eosin–stained kidney sections in the CYP2e1/ mice
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Fig. 10. The induction of p21mRNA and p21 protein in the kidney of
CYP2e1/ and CYP2e1/ mice treated with cisplatin. Agarose gel
(2%) electrophoresis of reverse transcription-polymerase chain reaction
(RT-PCR) products of p21 mRNA and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA (amplified at the same time for the
internal standard) are presented as indicated. Western blot was per-
formed by using a monoclonal anti-p21 antibody. Both p21 mRNA and
p21 protein were up-regulated in cisplatin-treated mice as comparedFig. 9. Agarose gel electrophoresis of DNA from kidney cortex of
to respective control.CYP2e1/ and CYP2e1/ mice with and without cisplatin treat-
ment. Column 1 is an oligonucleotide standard marker. Columns 2
and 4 are loaded with DNA from control mice of CYP2e1/ and
CYP2e1/ , respectively. Columns 3 and 5 are from cisplatin-treated
CYP2e1/ and CYP2e1/mice, respectively. Apoptotic DNA frag-
DISCUSSIONments were induced in CYP2e1/ (column 3) but not in other groups.
The importance of CYP in the pathologic process of
the kidney seems to be increasing [37–39]. Its role as a
site for ROM generation and a source of catalytic iron in
3 days after cisplatin injection. Exact quantification was the kidney has not been fully explored. We have recently
not possible because of the extensive necrosis present in demonstrated that exposure of LLC-PK1 cells (renal prox-
the kidney sections. To quantify the degree of apoptosis imal tubular cells) to cisplatin resulted in marked genera-
TUNEL assay was performed. Using this assay few stained tion of H2O2, loss of CYP2E1 content, increase in cata-
nuclei were noted in the kidney sections of the control lytic iron and hydroxyl radical formation accompanied
mice (Fig. 8). In the cysplatin-treated CYP2e1/ mice by significant cytotoxicity. Treatment with CYP2E1 in-
a significant increase in the apoptotic cells was observed hibitors markedly reduced H2O2 generation with the pres-
ervation of CYP2E1 content. There was also a markedboth in the proximal and distal regions of the nephron
decrease in catalytic iron and hydroxyl radical formationwhen compared to CYP2e1/mice (Fig. 8). DNA frag-
with significant attenuation of cytotoxicity [40].mentation as evidenced by the characteristic 180 bp lad-
In the current study, administration of cisplatin todering was attenuated in the cisplatin-treated CYP2e1/
CYP2e1/ mice resulted in marked reduction ofmice (Fig. 9).
CYP2E1 content associated with a significant increase inIn view of the importance of the cell cycle as a determi-
catalytic iron. CYP2e1/ mice prevented the catalyticnant of the fate of the cells, we examined the effect of
iron formation and provided marked functional and his-cisplatin on the cell cycle protein p21. Both RT-PCR and
tologic protection following cisplatin injection. Incuba-Western analysis indicated a significant up-regulation of
tion of the kidney slices from CYP2e1/ mice withp21 in the CYP2e1/ mice injected with cisplatin. Of
cisplatin resulted in a marked generation of H2O2, cata-interest was the induction of p21 in the CYP2e1/ lytic iron and hydroxyl radical along with significant cyto-
control mice with further up-regulation following admin- toxicity. These effects of cisplatin were significantly re-
istration of cisplatin (Fig. 10). duced in CYP2e1/ kidney slices. Similar results were
Direct incubation of the microsomes isolated from the observed on incubating the microsomes isolated from
CYP2e1/ kidney with cisplatin resulted in a marked kidney of CYP2e1/ and CYP2e1/ mice with cis-
increase in the H2O2 and catalytic iron release with sig- platin. Taken together our data strongly suggest that
nificant hydroxyl radical formation. This was attenuated CYP2E1 plays an important role in cisplatin-induced
when microsomes isolated from the CYP2e1/ kidney nephrotoxicity by serving as a major site for the genera-
tion of ROM and a significant source of iron capable ofwere exposed to cisplatin (Fig. 11).
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Fig. 11. Hydrogen peroxide generation (A ), catalytic iron release (B ), and hydroxyl radical formation (C ) from the microsomes isolated from
the kidney cortex of CYP2e1/ and CYP2e1/ mice 60 minutes following cisplatin (200 g/mL) treatment. Values are mean 
 SE, N 	 4.
*P  0.05, compared to respective controls.
catalyzing free radical reactions. We postulate that the significant attenuation of apoptosis that was evident in
the CYP2e1/ mice.interaction between cisplatin and CYP2E1 results in the
The p21 protein, an inhibitor of cyclin-dependent ki-generation of H2O2 that causes destruction of the heme
nase, is found in the nucleus of most quiescent cells atprotein with the release of heme and iron. The released
low levels [54]. It is induced to high levels by oxidativeiron then participates in the generation of the hydroxyl
stress and DNA damage effectively inhibiting the cellradical and other pathogenic oxidants resulting in injury.
cycle progression [23, 55]. By utilizing p21/ mice,Induction of HO-1 has been shown to be protective
Megyesi, Safirstein, and Price [56] have shown that p21in nephrotoxic models of renal injury [41, 42]. Recent
protects the cisplatin-induced kidney damage by pre-studies provide further genetic evidence that up-regula-
venting the DNA damaged cells from entering the celltion of HO-1 serves as an important adaptive mechanism
cycle, which would otherwise result in death from apo-in the protection of cells against oxidative injury [43, 44].
ptosis or necrosis. Inguaggiato et al have further demon-Bissell and Hammaker [45] based on their study with
strated that the mechanisms by which induction of HO-1endotoxin indicated that agents which promote the in-
protects against cisplatin-induced nephrotoxicity in-duction of HO-1 cause the release of heme from the
volves the p21 dependent mechanisms [44]. In the cur-CYP, which, in turn, causes the stimulation of HO-1. In
rent study both RT-PCR and Western analysis indicatedthe present study we have demonstrated that administra-
a significant up-regulation of P21 in the CYP2e1/tion of cisplatin to the CYP2e1/ mice resulted in
mice injected with cisplatin. Of particular interest wassignificant loss of CYP2E1 content in the kidney accom-
the induction of the p21 in the CYP2e1/ control micepanied by an increase in the catalytic iron and significant
with further up-regulation following administration ofinduction of the HO-1 in the tubules. This up-regulation
cisplatin. We postulate that the up-regulation of p21 inof HO-1 was markedly reduced in the cisplatin-treated
the control CYP2e1/mice could represent a compen-
CYP2e1/ mice.
satory mechanism that may be induced in response to
ROM plays an important role in cisplatin-induced apo-
the aberration or deletion of the CYP2e1 gene. This addi-
ptosis of the renal tubular cells [46]. Recent studies indi- tional up-regulation of p21 in cisplatin-treated CYP2e1/
cate that mitochondria are the principal sensors and thus mice might further contribute in preventing the DNA
critical in the initiation of the apoptotic cascade [47–49]. damaged cells entering the cell cycle. Experimentally,
However, little is known about what triggers apoptosis overexpression of p21 in tumor-bearing animals may ef-
in response to cisplatin. The prevailing assumption is fectively inhibit the growth/proliferation of the malignant
that all electron-transfer processes leading to ROM pro- cells and could serve as an interesting animal model for
duction are localized to the mitochondria [50, 51]. How- cancer study and attractive target for future drug design.
ever, consideration needs to be given to yet another
electron-transfer chain namely the microsomes via the
CONCLUSIONCYP system, which is crucial to the ROM-mediated cell
signaling and is present at high concentration in the en- Our results demonstrate a critical role of CYP2E1 in
doplasmic reticulum of most animal cells [52, 53]. Ad- cisplatin-induced nephrotoxicity and initiation of apo-
ptosis. It could stimulate the identification and localiza-ministration of cisplatin to CYP2e1/ mice resulted in
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P-450 IIE1 in the oxidation of many low molecular weight cancertion of specific CYP isozymes in the human renal tubular
suspects. Chem Res Toxicol 4:168–179, 1991
cells and the development of specific inhibitors that could 17. Lucas D, Farez C, Bardou LG, Vaisse J, et al: Cytochrome
P450 2E1 activity in diabetic and obese patients as assessed byprevent or ameliorate cisplatin-induced renal injury. A
chlorzoxazone hydroxylation. Fundam Clin Pharmacol 12:553–558,more thorough understanding of the renal stress re-
1998
sponse and its molecular interactions with the mitochon- 18. Mandl J, Banhegyi G, Kalapos MP, Garzo T: Increased oxida-
tion and decreased conjugation of drugs in the liver caused bydrial apoptotic pathway will certainly be important areas
starvation. Altered metabolism of certain aromatic compoundsof research in the future.
and acetone. Chem Biol Interact 96:87–101, 1995
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